Tech Company Financing Transactions
SeaBeLife Funding Round
SeaBeLife, based in Roscoff, raised $2.3 million from iXLife Capital and Femmes Business Angels.
Transaction Overview
Company Name
Announced On
10/1/2025
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Series A
Investors
iXLife Capital (Lead Investor)
Proceeds Purpose
The financing will support two core therapeutic programmes targeting dry age-related macular degeneration (AMD) and severe acute hepatitis.
Company Information
Company Status
Private & Independent
Industry
AdTech
Advanced Materials
Advanced Materials
Mailing Address
Place Georges Teissier
Roscoff, 29680
FR
Roscoff, 29680
FR
Phone
Website
Email Address
Overview
We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Morgane Rousselot
Chief Technical Officer
Claire Delehouzé
Browse more venture capital transactions:
Prev: 10/1/2025: Simplifya venture capital transaction
Next: 10/1/2025: Ansa Biotechnologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs